Capital Advisors Ltd’s ImmuCell ICCC Stock Holding History

Capital Advisors Ltd’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	98	–	–	﹤0.01%	1244
2026 Q1	$1K	Hold	98	–	–	﹤0.01%	1232
2025 Q4	$1K	Hold	98	–	–	﹤0.01%	1209
2025 Q3	$1K	Hold	98	–	–	﹤0.01%	1210
2025 Q2	$1K	Hold	98	–	–	﹤0.01%	1201
2025 Q1	$0	Sell	98 -2	-2%	-$10	﹤0.01%	1446
2024 Q4	$1K	Buy	+100	New	+$398	﹤0.01%	1221

Other funds holding ICCC

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Capital Advisors Ltd's ICCC Position: Q2 2026 in Review

Capital Advisors Ltd held its ImmuCell (ICCC) position steady in Q2 2026 at 98 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Capital Advisors Ltd first reported a position in ICCC in Q4 2024 and has held it in 7 quarters since. 3 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

Capital Advisors Ltd held 98 shares of ImmuCell worth $1K as of Q2 2026.
Capital Advisors Ltd left its ImmuCell share count unchanged in Q2 2026.
ImmuCell made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1244 holding.
Capital Advisors Ltd first reported a position in ImmuCell in Q4 2024 and has held it in 7 quarters since.
3 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.